Probiotics, particularly strains of Lactobacillus, may support both gut health (improving GI side effects) and vaginal/urinary flora (reducing UTI risk)
doi:10.1136/vr.102547
Walczak-Gazewska M, Szuliska M, Miller-Kasprzak E, Pupek-Musialik D, Bogdaski P (2018) The effect of nebivolol and ramipril on selected biochemical parameters, arterial stiffness, and circadian profile of blood pressure in young men with primary hypertension: a 12-week prospective randomized, open-label study trial
I see it as another call for unified approach to assessing the body composition (in humans)
Thats why Semaglutide is widely considered a breakthrough: it addresses the biological drivers of weight gain, not just behavior, and turns short bursts of effort into long-term momentum
The bottom line: Our findings suggest that GLP-1RA and SGLT2i (and especially SGLT2i with the lowest number needed to treat (NNT) for nearly all study outcomes) may be the preferred glucose-lowering agents for cardiovascular risk reduction in patients at moderate risk for CVD, building on and consistent with existing RCT evidence in the high-risk population. This report highlights potential preference for GLP-1 drugs as a first-line treatment for Type 2 diabetes related to its cardioprotective effect